Related references
Note: Only part of the references are listed.Membrane Env Liposomes Facilitate Immunization with Multivalent Full-Length HIV Spikes
Daniel P. Leaman et al.
JOURNAL OF VIROLOGY (2021)
Structure of HIV-1 gp41 with its membrane anchors targeted by neutralizing antibodies
Christophe Caillat et al.
ELIFE (2021)
An Engineered Biomimetic MPER Peptide Vaccine Induces Weakly HIV Neutralizing Antibodies in Mice
Shuai Shao et al.
ANNALS OF BIOMEDICAL ENGINEERING (2020)
HIV-1 Envelope and MPER Antibody Structures in Lipid Assemblies
Kimmo Rantalainen et al.
CELL REPORTS (2020)
Neutralizing Antibodies Targeting HIV-1 gp41
Christophe Caillat et al.
VIRUSES-BASEL (2020)
Mapping the immunogenic landscape of near-native HIV-1 envelope trimers in non-human primates
Christopher A. Cottrell et al.
PLOS PATHOGENS (2020)
An MPER antibody neutralizes HIV-1 using germline features shared among donors
Lei Zhang et al.
NATURE COMMUNICATIONS (2019)
Oligomeric Structure and Three-Dimensional Fold of the HIV gp41 Membrane-Proximal External Region and Transmembrane Domain in Phospholipid Bilayers
Byungsu Kwon et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2018)
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1
Kai Xu et al.
NATURE MEDICINE (2018)
The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects
Huan Liu et al.
PROTEIN & CELL (2018)
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability
Marit J. van Gils et al.
NATURE MICROBIOLOGY (2017)
Antigp41 membrane proximal external region antibodies and the art of using the membrane for neutralization
Nichole Cerutti et al.
CURRENT OPINION IN HIV AND AIDS (2017)
Potent and broad HIV-neutralizing antibodies in memory B cells and plasma
LaTonya D. Williams et al.
SCIENCE IMMUNOLOGY (2017)
Mapping out the intricate relationship of the HIV envelope protein and the membrane environment
Yoel A. Kiug et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2017)
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design
Dennis R. Burton et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
Cryo-EM structure of a native, fully glycosylated, cleaved HIV-1 envelope trimer
Jeong Hyun Lee et al.
SCIENCE (2016)
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody
Rui Kong et al.
SCIENCE (2016)
Structural basis for broad neutralization of HIV-1 through the molecular recognition of 10E8 helical epitope at the membrane interface
Edurne Rujas et al.
SCIENTIFIC REPORTS (2016)
The Atomic Structure of the HIV-1 gp41 Transmembrane Domain and Its Connection to the Immunogenic Membrane-proximal External Region
Beatriz Apellaniz et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
The three lives of viral fusion peptides
Beatriz Apellaniz et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2014)
Structure and Immunogenicity of a Peptide Vaccine, Including the Complete HIV-1 gp41 2F5 Epitope IMPLICATIONS FOR ANTIBODY RECOGNITION MECHANISM AND IMMUNOGEN DESIGN
Soraya Serrano et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Structural Basis for HIV-1 Neutralization by 2F5-Like Antibodies m66 and m66.6
Gilad Ofek et al.
JOURNAL OF VIROLOGY (2014)
A stamp on the envelope
Rogier W. Sanders et al.
NATURE (2014)
Rational Design of Membrane Proximal External Region Lipopeptides Containing Chemical Modifications for HIV-1 Vaccination
Vincent J. Venditto et al.
CLINICAL AND VACCINE IMMUNOLOGY (2013)
Antidotes, antibody-mediated immunity and the future of pharmaceutical product development
Salvador Eugenio C. Caoili
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition
David Lutje Hulsik et al.
PLOS PATHOGENS (2013)
Liposomes containing lipid A: an effective, safe, generic adjuvant system for synthetic vaccines
Carl R. Alving et al.
EXPERT REVIEW OF VACCINES (2012)
HIV Entry and Envelope Glycoprotein-mediated Fusion
Robert Blumenthal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
Jinghe Huang et al.
NATURE (2012)
Targeting Antibody Responses to the Membrane Proximal External Region of the Envelope Glycoprotein of Human Immunodeficiency Virus
Donatien Kamdem Toukam et al.
PLOS ONE (2012)
Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice
Mingkui Zhou et al.
VACCINE (2012)
Design considerations for liposomal vaccines: Influence of formulation parameters on antibody and cell-mediated immune responses to liposome associated antigens
Douglas S. Watson et al.
VACCINE (2012)
Structure-guided Alterations of the gp41-directed HIV-1 Broadly Neutralizing Antibody 2F5 Reveal New Properties Regarding its Neutralizing Function
Javier Guenaga et al.
PLOS PATHOGENS (2012)
Refining the Eosinophil Cationic Protein Antibacterial Pharmacophore by Rational Structure Minimization
Marc Torrent et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Cross-Reactive HIV-1-Neutralizing Human Monoclonal Antibodies Identified from a Patient with 2F5-Like Antibodies
Zhongyu Zhu et al.
JOURNAL OF VIROLOGY (2011)
Induction of Antibodies in Rhesus Macaques That Recognize a Fusion-Intermediate Conformation of HIV-1 gp41
S. Moses Dennison et al.
PLOS ONE (2011)
Advances in the design and delivery of peptide subunit vaccines with a focus on Toll-like receptor agonists
Matthew Black et al.
EXPERT REVIEW OF VACCINES (2010)
Ablation of the Complementarity-Determining Region H3 Apex of the Anti-HIV-1 Broadly Neutralizing Antibody 2F5 Abrogates Neutralizing Capacity without Affecting Core Epitope Binding
Jean-Philippe Julien et al.
JOURNAL OF VIROLOGY (2010)
Structural Details of HIV-1 Recognition by the Broadly Neutralizing Monoclonal Antibody 2F5: Epitope Conformation, Antigen-Recognition Loop Mobility, and Anion-Binding Site
Jean-Philippe Julien et al.
JOURNAL OF MOLECULAR BIOLOGY (2008)
The membrane-proximal external region of the human immunodeficiency virus type 1 envelope: Dominant site of antibody neutralization and target for vaccine design
Marinieve Montero et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2008)
The membrane-proximal external region of HIV-1 gp41: a vaccine target worth exploring
MB Zwick
AIDS (2005)
Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1
MB Zwick et al.
JOURNAL OF VIROLOGY (2005)
The C- and the N-terminal regions of glycoprotein 41 ectodomain fuse membranes enriched and not enriched with cholesterol, respectively
S Shnaper et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Characterization of molecular features, antigen-binding, and in vitro properties of IgG and IgM variants of 4E10, an anti-HIV type 1 neutralizing monoclonal antibody
R Kunert et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2004)
Passive immunization with the anti-HIV-1 human monoclonal antibody (hMAb) 4E10 and the hMAb combination 4E10/2F5/2G12
C Armbruster et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Structure and mechanistic analysis of the anti-human immunodeficiency virus type 1 antibody 2F5 in complex with its gp41 epitope
G Ofek et al.
JOURNAL OF VIROLOGY (2004)
Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: Putative role during viral fusion
T Suarez et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
